These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 9381270

  • 21. Monitoring and treatment of anti-D in pregnancy.
    Bettelheim D, Panzer S, Reesink HW, Csapo B, Pessoa C, Guerra F, Wendel S, Calda P, Sprogøe U, Dziegiel M, Aitokallio-Tallberg A, Koskinen S, Kuosmanen M, Legler TJ, Stein W, Villa S, Villa MA, Trespidi L, Acaia B, Vandenbussche FP, Brand A, de Haas M, Kanhai HH, Gounder D, Flanagan P, Donegan R, Parry E, Sefonte C, Skulstad SM, Hervig T, Flesland Ø, Zupańska B, Uhrynowska M, Lapaire O, Zhong XY, Holzgreve W.
    Vox Sang; 2010 Aug 01; 99(2):177-92. PubMed ID: 20331536
    [Abstract] [Full Text] [Related]

  • 22. Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping.
    Lo YM.
    Transfus Clin Biol; 2006 Aug 01; 13(1-2):50-2. PubMed ID: 16563836
    [Abstract] [Full Text] [Related]

  • 23. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA, Wagner FF, Fernandes BJ, Li W, Flegel WA.
    Transfusion; 2005 Oct 01; 45(10):1554-60. PubMed ID: 16181204
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [The importance of laboratory diagnosis in allo-immunization through pregnancy and hemolytic disease of the newborn].
    Florea DP.
    Rev Med Chir Soc Med Nat Iasi; 2010 Oct 01; 114(1):211-3. PubMed ID: 20509304
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Prevention of fetomaternal anti-rhesus-D allo-immunization: methods used and topics discussed].
    Carbonne B, Goffinet F, Marpeau L.
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb 01; 35(1 Suppl):1S85-1S86. PubMed ID: 16495832
    [No Abstract] [Full Text] [Related]

  • 30. The introduction of human monoclonal anti-D for therapeutic use.
    Fletcher A, Thomson A.
    Transfus Med Rev; 1995 Oct 01; 9(4):314-26. PubMed ID: 8541714
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Prevention of feto-maternal Rh isoimmunization].
    Gómez Piña de la Peza, Lamadrid Montemayor F, Flores Rodríguez JJ.
    Ginecol Obstet Mex; 1971 Jan 01; 29(171):99-104. PubMed ID: 4996660
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Immunoprophylaxis with anti D immunoglobulins in Rh negative women.
    Gupta I, Jolly JG, Gupta AN.
    Indian J Med Res; 1987 Jun 01; 85():656-8. PubMed ID: 2824352
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Monoclonal anti-D antibodies to prevent alloimmunization: lessons from clinical trials.
    Béliard R.
    Transfus Clin Biol; 2006 Jun 01; 13(1-2):58-64. PubMed ID: 16580863
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Serological testing during pregnancy in women given routine antenatal anti-D Ig prophylaxis.
    de Silva PM, Knight RC.
    Transfus Med; 1997 Dec 01; 7(4):323-4. PubMed ID: 9510934
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.